Articares revolutionises hand and wrist rehabilitation with the innovative ‘ReHandyBot’
Articares, in collaboration with FHT and other partners, has developed 'ReHandyBot', which offers gamified therapy programmes tailored to patients needing upper limb rehabilitation.
external pageArticares, a Singapore-based company pioneering intelligent rehabilitation solutions, is thrilled to introduce ReHandyBot, an innovative robot designed for sensorimotor hand and wrist therapy.
Developed in close partnership with the Rehabilitation Engineering Laboratory (RELab) at ETH Zurich and external pageClinica Hildebrand Centro di riabilitazione Brissago, Switzerland, this new product is the result of over 15 years of advanced research on revolutionising technology-based hand rehabilitation.
Expanding on a decade of success with the internationally recognised H-Man, an arm rehabilitation robot developed in collaboration with Nanyang Technological University and Tan Tock Seng Hospital (TTSH), Articares extends its upper limb rehabilitation suite with the launch of ReHandyBot.
ReHandyBot offers gamified therapy programs tailored to the unique needs of patients recovering from conditions such as stroke or orthopaedic injury affecting upper limb function. It automatically adapts to the individual's progress, and monitors improvement in real-time.
“By providing advanced haptic feedback, ReHandyBot enables patients to feel and manipulate virtual objects. This unique approach can simulate a wide range of daily activities, which is essential for regaining hand and wrist function.” says Prof. Roger Gassert of ETH Zurich.
Articares' commitment to user-friendly and smart rehabilitation robotics ensures that ReHandyBot can be used with little to no supervision, increasing therapy efficiency and empowering patients to enhance their hand and wrist rehabilitation after normal therapy hours or even in the comfort of their homes. In fact, Articares and RELab are collaborating within the Future Health Technologies (FHT) programme of the Singapore-ETH Centre, carrying out cutting-edge research and innovation, and conducting clinical trials with TTSH to validate the clinical impact of these technologies and bring them even closer to patients’ homes.
“ReHandyBot uniquely integrates our approach to the restoration of hand function into a robotic solution. It's a remarkable innovation that we fully endorse.”, says Dr. Paolo Rossi, neurologist and medical co-director of the Clinica Hildebrand Centro di riabilitazione Brissago.
The partnership between Articares and RELab reflects a shared vision of advancing rehabilitation technology and translating novel research into future gold-standard healthcare. Integrating Articares' expertise in developing smart and clinically validated solutions with RELab's expertise in robot-assisted rehabilitation of hand function, ReHandyBot increases accessibility to high quality rehabilitation.
"We are incredibly excited to partner with RELab and bring ReHandyBot to the global market. This innovation is more than just a technological breakthrough; it is a leap towards improving the quality of life for countless individuals in need of specialised hand and wrist therapy," says Asif Hussain, CEO of Articares.
ReHandyBot will be introduced and demoed at RehabWeek 2023 from 24-28 September in Singapore. For further information or to book a demo, please reach out via external pagewww.articares.com.